March 2022 - Cancer Currents Blog
-
Carvykti Approval Marks Second CAR T-Cell Therapy for Multiple MyelomaPeople with advanced multiple myeloma now have another option for CAR T-cell therapy with the recent approval of ciltacabtagene autoleucel (Carvykti). Like the first approved CAR T-cell therapy, Carvykti targets the BCMA protein on myeloma cells.
-
Darolutamide Extends Survival for Some People with Metastatic Prostate CancerAdding darolutamide (Nubeqa) to ADT and docetaxel (Taxotere) can improve how long men with hormone-sensitive metastatic prostate cancer live without causing more side effects, results from the ARASENS trial show.
-
Can Artificial Intelligence Help See Cancer in New, and Better, Ways?Researchers have been developing artificial intelligence (AI) tools that could make cancer imaging faster, more accurate, and more informative. But there are also questions about whether these tools are ready for doctors’ offices, whether they will actually help people, and whether that benefit will reach all—or only some—patients.
-
New on NCI’s Websites for March 2022NCI periodically provides updates on new websites and other online content of interest to the cancer community. See selected content that has been added as of March 2022.
-
Severe Side Effects of Cancer Treatment Are More Common in Women than MenWomen are more likely than men to experience severe side effects from cancer treatments such as chemotherapy, targeted therapy, and immunotherapy, a new study finds. Researchers hope the findings will increase awareness of the problem and help guide patient care.
-
Trametinib Is a New Treatment Option for Rare Form of Ovarian CancerNew results from a large study show that trametinib (Mekinist) is an effective treatment for low-grade serous ovarian cancer. The findings are the first strong evidence that this rare type of ovarian cancer should be treated differently from other forms of the disease.
-
Telehealth-Based Cancer Care Surged during COVID. Will It Continue?Experts say studies are needed on how to best transition telehealth from a temporary solution during the pandemic to a permanent part of cancer care that’s accessible to all who need it.
-
Good News and Cautions about Pregnancy for Childhood Cancer SurvivorsAs adults, survivors of childhood cancer aren’t any less likely to have healthy babies than those without a history of cancer, a new study shows. However, they may have more health risks during pregnancy, warranting more intensive obstetric care.